Creative

Kinvard Bio is a spin-out biotech from the Myers Laboratory at Harvard University’s Department of Chemistry and Chemical Biology. The company is developing a novel, highly differentiated class of ribosome targeting antibiotics. Kinvard’s approach has resulted in broad-spectrum, IV / oral agents to address acute and chronic infections associated with the highest unmet patient need and commercial potential.

Zer0 to 5ive gave Kinvard’s website a refreshed look and designed accompanying marketing materials including an investor slick and powerpoint template to match the site.